Improving Hepatitis Vaccination Series Completion in Patients Awaiting Liver Transplantation

The aim of this quality improvement project was to improve hepatitis A and B vaccination rates by 20% in patients listed for liver transplant by improving vaccine tracking, ordering/scheduling practices, out-of-network vaccinations, and flagging electronic health records. We audited 101 records; 44 patients were vaccine-deficient. Combined vaccine completion rates improved 94.6% (44.7%-87.0%) after implementing the educational and health record interventions. We believe the results of this study have implications for improving survival and decreasing complication rates for patients with chronic liver disease. •Risks of posttransplant complications are higher in patients nonimmune to hepatitis A and B virus.•Prophylaxis may be costly for nonvaccinated patients who receive hepatitis B virus core-positive organs.•A discrepancy exists among patients requiring and completing hepatitis A and B virus vaccination.•Evidence-based interventions significantly improved vaccination completion rates.